tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AUPH Stock Latest News

Aurinia Pharmaceuticals upgraded to Buy from Hold at Jefferies
The FlyAurinia Pharmaceuticals upgraded to Buy from Hold at Jefferies
15d ago
AUPH
Aurinia Pharmaceuticals Reports Strong Q3 2025 Earnings
PremiumCompany Announcements
Aurinia Pharmaceuticals Reports Strong Q3 2025 Earnings
17d ago
AUPH
Aurinia Pharma’s Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Aurinia Pharma’s Earnings Call Highlights Growth and Challenges
17d ago
AUPH
Aurinia downgraded to Sector Perform from Outperform at RBC Capital
PremiumThe Fly
Aurinia downgraded to Sector Perform from Outperform at RBC Capital
17d ago
AUPH
Promising Sales and Market Potential of Lupkynis Drive Buy Rating for Aurinia Pharmaceuticals
PremiumRatings
Promising Sales and Market Potential of Lupkynis Drive Buy Rating for Aurinia Pharmaceuticals
17d ago
AUPH
Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance
PremiumCompany AnnouncementsAurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance
18d ago
AUPH
Aurinia Pharmaceuticals Reports Strong Q3 2025 Growth and Raises Sales Guidance
Premium
Company Announcements
Aurinia Pharmaceuticals Reports Strong Q3 2025 Growth and Raises Sales Guidance
18d ago
AUPH
Aurinia Pharmaceuticals reports Q3 EPS 23c, consensus 16c
Premium
The Fly
Aurinia Pharmaceuticals reports Q3 EPS 23c, consensus 16c
18d ago
AUPH
Aurinia Pharmaceuticals raises FY25 revenue view to $275M-$280M from $260M-$270M
PremiumThe Fly
Aurinia Pharmaceuticals raises FY25 revenue view to $275M-$280M from $260M-$270M
18d ago
AUPH
Midday Fly By: AWS in deal with OpenAI, Kimberly-Clark to buy Kenvue
PremiumThe Fly
Midday Fly By: AWS in deal with OpenAI, Kimberly-Clark to buy Kenvue
18d ago
BA
DD
Aurinia Pharmaceuticals to Announce Q3 2025 Financial Results and Business Update
PremiumCompany Announcements
Aurinia Pharmaceuticals to Announce Q3 2025 Financial Results and Business Update
19d ago
AUPH
FDA official resigns, sued by Aurinia Pharmaceuticals, WSJ reports
PremiumThe Fly
FDA official resigns, sued by Aurinia Pharmaceuticals, WSJ reports
19d ago
AUPH
Aurinia Pharmaceuticals (AUPH) Q3 Earnings Cheat Sheet
PremiumPre-EarningsAurinia Pharmaceuticals (AUPH) Q3 Earnings Cheat Sheet
25d ago
AUPH
Aurinia Pharmaceuticals Advances Voclosporin Study in Young Lupus Nephritis Patients
Premium
Company Announcements
Aurinia Pharmaceuticals Advances Voclosporin Study in Young Lupus Nephritis Patients
25d ago
AUPH
Aurinia Pharmaceuticals Advances Lupus Nephritis Study in Young Patients
Premium
Company Announcements
Aurinia Pharmaceuticals Advances Lupus Nephritis Study in Young Patients
25d ago
AUPH
Aurinia Pharmaceuticals to Present New LUPKYNIS Data at Key Conferences
PremiumCompany Announcements
Aurinia Pharmaceuticals to Present New LUPKYNIS Data at Key Conferences
1M ago
AUPH
Aurinia ‘stands behind’ favorable benefit/risk profile of LUPKYNIS
PremiumThe Fly
Aurinia ‘stands behind’ favorable benefit/risk profile of LUPKYNIS
2M ago
AUPH
Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction
PremiumCompany Announcements
Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction
2M ago
AUPH
Aurinia drops after FDA official criticizes voclosporin
PremiumThe Fly
Aurinia drops after FDA official criticizes voclosporin
2M ago
AUPH
Promising Drug Pipeline and Positive Trial Results Drive Buy Rating for Aurinia Pharmaceuticals
PremiumRatingsPromising Drug Pipeline and Positive Trial Results Drive Buy Rating for Aurinia Pharmaceuticals
2M ago
AUPH
Aurinia Pharmaceuticals: Strong Financial Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
Aurinia Pharmaceuticals: Strong Financial Performance and Promising Pipeline Drive Buy Rating
4M ago
AUPH
Aurinia Pharmaceuticals: Strong Financial Performance and Promising Future Justify Buy Rating
Premium
Ratings
Aurinia Pharmaceuticals: Strong Financial Performance and Promising Future Justify Buy Rating
4M ago
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >